Income Statement (TTM)
Regeneron Pharmaceuticals, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7,938 | 8,497 | 9,198 | 12,384 | 13,543 | 16,072 | 16,508 | 14,227 | 13,710 | 12,173 | 12,370 | 12,671 | 13,097 | 13,117 | 13,100 | 13,489 | 13,847 | 14,202 | 14,086 | 14,214 |
| Change (%) | 7.05 | 8.24 | 34.64 | 9.36 | 18.67 | 2.72 | -13.82 | -3.63 | -11.21 | 1.62 | 2.43 | 3.37 | 0.15 | -0.13 | 2.97 | 2.65 | 2.56 | -0.82 | 0.91 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 3,531 | 3,767 | 4,105 | 4,515 | 4,675 | 5,298 | 5,495 | 5,179 | 5,289 | 5,153 | 5,463 | 5,862 | 6,144 | 6,255 | 6,378 | 6,568 | 6,819 | 7,102 | 7,212 | 7,484 |
| Change (%) | 6.67 | 8.96 | 10.00 | 3.54 | 13.32 | 3.73 | -5.76 | 2.13 | -2.58 | 6.02 | 7.30 | 4.82 | 1.80 | 1.97 | 2.98 | 3.82 | 4.15 | 1.54 | 3.77 | |
| % of Revenue | 44.49 | 44.33 | 44.63 | 36.46 | 34.52 | 32.96 | 33.29 | 36.40 | 38.58 | 42.33 | 44.16 | 46.26 | 46.91 | 47.68 | 48.69 | 48.69 | 49.25 | 50.01 | 51.20 | 52.65 |
| Gross Operating Profit | 4,406 | 4,730 | 5,093 | 7,869 | 8,868 | 10,774 | 11,013 | 9,048 | 8,421 | 7,020 | 6,907 | 6,809 | 6,953 | 6,862 | 6,722 | 6,921 | 7,028 | 7,100 | 6,874 | 6,730 |
| Change (%) | 7.35 | 7.67 | 54.51 | 12.69 | 21.50 | 2.21 | -17.84 | -6.93 | -16.63 | -1.61 | -1.42 | 2.11 | -1.30 | -2.05 | 2.96 | 1.55 | 1.02 | -3.18 | -2.08 | |
| % of Revenue | 55.51 | 55.67 | 55.37 | 63.54 | 65.48 | 67.04 | 66.71 | 63.60 | 61.42 | 57.67 | 55.84 | 53.74 | 53.09 | 52.32 | 51.31 | 51.31 | 50.75 | 49.99 | 48.80 | 47.35 |
| SG&A | 1,459 | 1,346 | 1,384 | 1,451 | 1,569 | 1,825 | 1,869 | 1,931 | 2,015 | 2,116 | 2,267 | 2,443 | 2,554 | 2,631 | 2,719 | 2,826 | 2,900 | 2,954 | 2,898 | 2,774 |
| Change (%) | -7.75 | 2.85 | 4.80 | 8.14 | 16.32 | 2.43 | 3.30 | 4.36 | 5.01 | 7.14 | 7.75 | 4.56 | 3.02 | 3.34 | 3.93 | 2.62 | 1.88 | -1.90 | -4.30 | |
| % of Revenue | 18.38 | 15.84 | 15.05 | 11.71 | 11.58 | 11.35 | 11.32 | 13.57 | 14.70 | 17.38 | 18.33 | 19.28 | 19.50 | 20.06 | 20.76 | 20.95 | 20.94 | 20.80 | 20.58 | 19.51 |
| R&D | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| OpEx | 4,817 | 4,832 | 5,208 | 5,704 | 6,069 | 7,077 | 7,339 | 7,098 | 7,205 | 7,179 | 7,660 | 8,251 | 8,690 | 8,884 | 9,096 | 9,393 | 9,719 | 10,057 | 10,110 | 10,258 |
| Change (%) | 0.32 | 7.78 | 9.52 | 6.39 | 16.61 | 3.71 | -3.28 | 1.51 | -0.37 | 6.70 | 7.72 | 5.32 | 2.23 | 2.39 | 3.27 | 3.46 | 3.48 | 0.53 | 1.45 | |
| % of Revenue | 60.69 | 56.87 | 56.63 | 46.06 | 44.81 | 44.03 | 44.46 | 49.89 | 52.55 | 58.97 | 61.92 | 65.12 | 66.35 | 67.73 | 69.43 | 69.64 | 70.19 | 70.81 | 71.78 | 72.16 |
| Operating Income | 3,120 | 3,665 | 3,989 | 6,680 | 7,474 | 8,995 | 9,169 | 7,128 | 6,505 | 4,994 | 4,710 | 4,420 | 4,407 | 4,233 | 4,004 | 4,096 | 4,128 | 4,145 | 3,975 | 3,957 |
| Change (%) | 17.44 | 8.86 | 67.45 | 11.89 | 20.35 | 1.93 | -22.25 | -8.75 | -23.23 | -5.68 | -6.17 | -0.29 | -3.95 | -5.41 | 2.29 | 0.80 | 0.40 | -4.10 | -0.47 | |
| % of Revenue | 39.31 | 43.13 | 43.37 | 53.94 | 55.19 | 55.97 | 55.54 | 50.11 | 47.45 | 41.03 | 38.08 | 34.88 | 33.65 | 32.27 | 30.57 | 30.36 | 29.81 | 29.19 | 28.22 | 27.84 |
| Interest Expense | -49 | -57 | -65 | -70 | -58 | -57 | -56 | -55 | -56 | -59 | -64 | -70 | -72 | -73 | -71 | -67 | -63 | -55 | -48 | -37 |
| Change (%) | 16.60 | 14.94 | 7.19 | -17.26 | -1.21 | -1.75 | -2.31 | 2.00 | 5.88 | 7.41 | 9.09 | 3.59 | 1.25 | -2.60 | -5.77 | -5.97 | -12.38 | -13.41 | -23.43 | |
| % of Revenue | -0.61 | -0.67 | -0.71 | -0.57 | -0.43 | -0.36 | -0.34 | -0.39 | -0.41 | -0.49 | -0.52 | -0.55 | -0.55 | -0.56 | -0.54 | -0.50 | -0.45 | -0.39 | -0.34 | -0.26 |
| Net Income | 3,156 | 3,513 | 4,004 | 6,205 | 6,996 | 8,075 | 7,934 | 5,687 | 5,370 | 4,338 | 4,183 | 4,299 | 3,991 | 3,954 | 3,858 | 4,322 | 4,654 | 4,413 | 4,499 | 4,459 |
| Change (%) | 11.32 | 13.96 | 54.99 | 12.73 | 15.44 | -1.75 | -28.32 | -5.57 | -19.21 | -3.59 | 2.78 | -7.16 | -0.94 | -2.42 | 12.02 | 7.70 | -5.20 | 1.96 | -0.90 | |
| % of Revenue | 39.76 | 41.35 | 43.53 | 50.11 | 51.65 | 50.25 | 48.06 | 39.97 | 39.17 | 35.64 | 33.81 | 33.93 | 30.47 | 30.14 | 29.45 | 32.04 | 33.61 | 31.07 | 31.94 | 31.37 |
Source: Capital IQ
